New possibilities for vector-borne disease control are revealed by Duvall et al. (2019) , who link hostseeking behavioral modulation in Aedes aegypti to neuropeptide Y (NPY)-like receptor 7. Small-molecule screening yields agonist compounds able to activate NPYLR7 and suppress attraction to hosts.
Understanding the genetic underpinnings of behavior has been long pursued in model organisms but only recently has been better explored in disease vectors (Duvall et al., 2017) . With the advent of more efficient gene editing tools, as well as better curated genome datasets, medically important mosquito species are now subject to precise DNA manipulation, allowing the correct association between structure and function of molecular components and their involvement in a particular behavior. Mating, host-seeking, biting, blood-feeding, and egg-laying are among the key behaviors that hematophagous mosquitoes bear in common, all of which still lack an adequate molecular characterization. Piecing together this puzzle can be very rewarding for both basic and applied science by not only providing a better understanding of complex biological phenomena but also identifying suitable targets for genetic or drug intervention.
Highly anthropophilic and perfectly adapted to urban habitats, Aedes aegypti is a major player among vector species, being able to transmit an array of viruses that cause dengue, Zika, chikungunya, and other serious diseases. Estimates point to 390 million annual cases across the globe for dengue alone (Bhatt et al., 2013) . Transmission occurs when mosquitoes bite infected human individuals, spreading the infection in subsequent feeding cycles. Developing vaccines to immunize humans or suppressing mosquito populations are the strategies usually employed to attenuate transmission. Stopping mosquitoes from biting could be another.
In this issue of Cell, Duvall et al. (2019) dig deep into the mechanism underlying Ae. aegypti attraction to humans. In an elegant body of work, the authors use a combination of biochemical and behavioral methods to investigate the role of neuropeptide Y (NPY)-related signaling in post-feeding suppression of female hostseeking behavior, which usually lasts between 3 and 4 days following a blood meal. It has been exhaustively reported that, during this period, mosquitoes shift their metabolism to egg production (vitellogenesis) and become insensitive to host odors, thus reducing biting frequency and hematophagy. While abdominal distention might account for the early phase of behavior suppression (days 1 and 2 after blood-feeding), the underlying signals that lock mosquitoes at this state for longer are mostly unknown. Some evidence, however, suggest that peptidergic signaling, most likely through NPY receptors, could be involved (Brown et al., 1994; Liesch et al., 2013) .
NPY (and NPY-like) receptors are cellsurface proteins belonging to the class A or rhodopsin-like G-protein-coupled receptor (GPCR) family. Upon specific combinations of receptor type and peptide ligands, intracellular signaling pathways promote modulatory effects on several biological processes, including circadian rhythms, neuronal excitability, stress response, and food intake (Brothers and Wahlestedt, 2010) . Not surprisingly, abnormal regulation of NPY-related signaling leads to a wide range of metabolic disorders, which have propelled the development of drugs with high affinity to NPY human receptors (Brothers and Wahlestedt, 2010) . Due to evolutionary conservation of NPY-related pathways across species, these drugs could potentially bind to mosquito NPY-like receptors, serving as powerful tools to investigate its functional role in host-seeking behavior. This rationale is adapted by Duvall et al. to an initial behavior screening of Ae. aegypti fed human NPY receptor drugs. Should activation of NPYsignaling pathways promote hostseeking suppression, then agonists mixed with a saline meal would induce this behavior, and antagonists mixed with a blood meal would interfere with it. Out of 10 compounds tested, 3 induced dose-dependent behavior responses: 2 agonists, TM30335 and TM30338, and 1 antagonist, BIIE0246. Among the agonists, TM30335 showed the highest potency. Remarkably, all 3 compounds target the same human NPY Y2 receptor, which is the closest relative of insect NPY-like receptors (Nä ssel and Wegener, 2011), supporting an initial hypothesis connecting receptors of this class to host-seeking. To further investigate this point, the authors develop a high-throughput cell-based assay to challenge all 49 predicted neuropeptide receptors of Ae. aegypti with the agonist TM33035. Only two of these receptors, NPYLR5 and NPYLR7, both belonging to the NPY-like family, were able to respond to the agonist. Additional dose-response analysis with TM30335 and BIIE0246 indicated that NPYLR7 was the most sensitive, assigning this receptor as the main candidate for driving host-seeking behavior.
In an attempt to identify Ae. aegyptispecific agonists, with no cross-reactivity to human NPY receptors, the authors challenge NPYLR7 with 265,211 unique small molecules. Out of those, 24 are able to bind and robustly activate Ae. aegypti NPYLR7 in vitro, but this number is reduced to 6 following in vivo behavior assays. To check how selective these molecule interactions are, the 6 compounds were counter-screened to all 49 mosquito neuropeptide receptors, as well as to all 4 human NPY receptors. Notably, the 6 compounds bind selectively to Ae. aegypti NPYLR7, not activating any of the human receptor variants. The authors also notice a chemical structure similarity among the most potent molecules, termed 17 and 18, sharing a minimal quinazoline scaffold. Further refinement of molecule structure shall be necessary for achieving more potency and a longer-lasting behavioral effect.
Even though drug testing points to NPYLR7 as a modulator of host-seeking suppression, the final verdict comes with the behavioral assays with loss-of-function mutants. Using the CRISPR-Cas9 gene editing system, the authors induce N-terminal indels in NPYLR7 and recover a null mutation that truncates the recep-tor's coding sequence near the first transmembrane domain. The NPYLR7deficient mutant is unable to sustain host-seeking suppression following a blood meal and is refractory to both human and mosquito receptor agonists. Nonetheless, it is intriguing that the mutant recovery is gradual, still manifesting partial host-seeking suppression after 2-3 days. This response could be the result of residual abdominal distention, due to a slower blood-meal digestion, or to alternative receptors acting synergistically with NPYLR7 to modulate suppression.
Besides unravelling a functional link between NPYLR7 and behavior, the study by Duvall et al. also includes a deorphanization in vitro screening of all the endogenous Ae. aegypti receptors (49) and peptide ligands (61). As expected, preliminary data analysis reveals a rather com-plex scenario, in which receptors bind to one or multiple ligands with variable degrees of specificity. NPYLR7, for instance, binds to 9 peptide ligands, including FMRFa1, FMRFa3, FMRFa10, MIP-1, sNPF-1, sNPF-2+4, sNPF-3, leucokinin, and AAEL011702A. Functional characterization of these ligands, and how they modulate host-seeking suppression, awaits further investigation.
The authors conclude their study by testing the ability of NPYLR7 agonist, compound 18, to prevent seeking, biting, and blood-feeding on a live host. Here, Ae. aegypti females are fed the agonist and allowed to recover for 2 days before being offered free access to a live, anesthetized mouse. Blood-feeding levels were remarkably low in these individuals, comparable to a control treatment group fed fresh blood, providing additional evidence that activation of NPYLR7 drives most if not all key behaviors leading to post-feeding refractoriness to hosts. Corroborating this view, NPYLR7deficient Ae. aegypti are resistant to the agonist-mediated suppression and exhibit higher blood-feeding levels.
Altogether, this elegant piece of work provides compelling evidence of NPYLR7 as a core modulator of feeding behavior in Ae. aegypti. One could postulate a simplified model where, following a blood meal, the NPYLR7-signaling pathway is switched on, inducing a satiety state characterized by diminished host-seeking, biting, and blood-feeding activity. Here, downregulation of feeding-associated behavior could have evolved to shift energy reserves to vitellogenesis, egg-laying, and other vital processes. As these are gradually fulfilled, NPYLR7 signaling is switched off, releasing behavior suppression and promoting a new blood-feeding cycle. Future research must enrich this model with new add-ons, such as tissue expression data of NPYLR7 and its endogenous peptide ligands, bringing to life the cellular network underlying behavior modulation. For instance, could NPYLR7 be expressed in olfactory neurons, modulating its sensitivity to host odors?
By preventing host-seeking and subsequent feeding behaviors, activation of NPYLR7 could make Ae. aegypti less prone to transmit pathogens, opening new possibilities for disease control (Figure 1) . Oral-administration of drug Blood-feeding locks Ae. aegypti females into a satiety state that usually lasts between 3 and 4 days, when they neither respond to host odors nor bite and feed. This behavior response is naturally driven by the activation of neuropeptide Y-like receptor 7 (NPYLR7) through endogenous peptide ligands that still need to be functionally characterized (dotted black line with an arrow). Drug screening reveals quinazolinederived agonist compounds capable of binding and activating NPYLR7, which also leads to host-seeking behavior suppression and opens new possibilities for disease control.
agonists could be adapted to attraction traps, reducing feeding rates of natural populations. Alternatively, endogenous peptide ligands, yet to be functionally described, could be delivered in the seminal fluid of transgenic males (Alfonso-Parra et al., 2014) , activating female's NPYLR7 after copula. Both options may lead to fitness costs, since reducing feeding rates may also decrease fecundity (i.e., egg numbers). Other notso-obvious aspects, such as fertility, mating, and longevity, still need to be investigated. These byproducts, however, could be a desired consequence for control interventions and help crashing local vector population numbers. If successful in Ae. aegypti, similar strategies using the same agonists or endogenous ligands could be applied to other mosquito species, considering a high degree of structural conservation between homologous NPYRL7 in insects. But make no mistake here: mosquitoes, like every other living organism, evolve and adapt to diverse environmental conditions, turning an efficient method obsolete in a short time frame. To circumvent the selection of resistant individuals, behavioral approaches could be combined to other innovative methods, such as those employing pathogen-blocking endosymbionts (e.g., Wolbachia) (Caragata et al., 2016) or gene drives (Kyrou et al., 2018) .
Finally, it is exciting to witness neurogenetics research transforming our understanding of mosquito behavior, and possibly contributing to vector-borne disease control. Despite not catching attention to field pioneers like Seymour Benzer, who devoted his studies to fruit flies, one could bet he would be proud to see Vosshall's group's current breakthroughs on vector biology.
Through dissecting the link between spatial genome organization and DNA replication timing, Sima et al. (2018) discover early replicating control elements (ERCEs), a new type of cis-acting elements that regulate replication timing, transcription, and multiple layers of three-dimensional features of genome organization. The study has important implications for unraveling control elements of high-order genome structure and function.
The DNA-replication timing program in eukaryotic cells duplicates the genetic materials during cell division with a highly regulated temporal pattern that is also spatially correlated with highorder genome structure. However, the molecular mechanisms underlying the precise program for replication timing remain poorly understood. Advances in
